Used in research for its potential as a selective antagonist of the prostaglandin E2 receptor EP4 subtype, showing promise in studies related to inflammation, pain, and cancer. It has been investigated for its ability to modulate immune responses and inhibit tumor growth in preclinical models. Also explored for its role in reducing bone resorption, suggesting possible applications in osteoporosis and other bone-related disorders. Due to its specific receptor targeting, it serves as a valuable tool compound in pharmacological studies aiming to understand EP4 receptor signaling pathways.